MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia

H. Sato, H. Preisler, R. Day, A. Raza, R. Larson, G. Browman, J. Goldberg, R. Vogler, H. Grunwald, A. Gottlieb, J. Bennett, M. Gottesman, I. Pastan

Research output: Contribution to journalArticlepeer-review

191 Scopus citations

Fingerprint

Dive into the research topics of 'MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry